Log In
BCIQ
Print this Print this
 

ANG1007

  Manage Alerts
Collapse Summary General Information
Company Angiochem Inc.
DescriptionAngiopep-2 peptide conjugated to three doxorubicin molecules
Molecular Target Low-density lipoprotein-related protein 1 alpha-2-macroglobulin receptor (LRP1) (CD91)
Mechanism of ActionDNA intercalating agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat brain cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today